| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
2,856,395 | 2,646,897 | 2,225,601 | 1,863,406 | 8,935,611 |
| Cost of Revenue
|
-297,998 | -295,279 | -237,826 | -237,345 | -7,605,445 |
|
Gross Profit
|
2,558,397 | 2,351,618 | 1,987,775 | 1,626,061 | 1,330,166 |
| Selling, General and Administrative Expenses
|
-958,086 | -891,783 | -821,119 | -704,287 | -480,303 |
| Depreciation, Amortization and Depletion
|
-152,133 | -135,848 | -104,463 | -85,453 | -63,613 |
| Other Income/Expense, Operating
|
-249,366 | -227,720 | -189,681 | -154,484 | -121,521 |
|
Operating Income/Expenses
|
-1,375,649 | -1,255,351 | -1,115,263 | -944,224 | -665,437 |
|
Total Operating Profit/Loss
|
1,182,748 | 1,096,267 | 872,512 | 681,837 | 664,729 |
| Total Net Finance Income/Expense
|
287,524 | 272,594 | 350,138 | 241,618 | 17,360 |
| Net Investment Income
|
24,060 | 24,060 | -2,953 | 43,409 | 37,904 |
| Irregular Income/Expenses
|
-5,971 | -- | -- | -- | -- |
|
Other Income/Expense, Non-Operating
|
-535 | 1,061 | 7,034 | -24,255 | -54 |
|
Non-Operating Income/Expenses, Total
|
297,766 | 297,715 | 354,219 | 260,772 | 55,210 |
|
Pretax Income
|
1,480,514 | 1,393,983 | 1,226,730 | 942,609 | 719,939 |
|
Provision for Income Tax
|
-354,888 | -331,457 | -301,567 | -244,287 | -155,800 |
|
Net Income from Continuing Operations
|
1,125,626 | 1,062,526 | 925,163 | 698,322 | 564,139 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,125,626 | 1,062,526 | 925,163 | 698,322 | 564,139 |
|
Net Income after Non-Controlling/Minority Interests
|
1,125,626 | 1,062,526 | 925,163 | 698,322 | 564,139 |
|
Net Income Available to Common Stockholders
|
1,125,626 | 1,062,526 | 925,163 | 698,322 | 564,139 |
|
Diluted Net Income Available to Common Stockholders
|
1,125,626 | 1,062,526 | 925,163 | 698,322 | 564,139 |
| Basic EPS
|
35.70 | 33.72 | 29.69 | 22.52 | 18.21 |
| Diluted EPS
|
35.58 | 33.61 | 29.59 | 22.41 | 18.17 |
|
Basic Weighted Average Shares Outstanding
|
31,539.09 | 31,511.46 | 31,160.22 | 31,012.12 | 30,975.33 |
|
Diluted Weighted Average Shares Outstanding
|
31,648.87 | 31,610.81 | 31,263.98 | 31,156.99 | 31,046.03 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,201,961 | 1,121,389 | 876,592 | 700,991 | 702,579 |
|
EBITDA
|
1,354,094 | 1,257,237 | 981,055 | 786,444 | 766,192 |
|
Normalized EBITDA
|
1,412,766 | 1,273,783 | 1,019,167 | 771,084 | 729,438 |
|
Normalized Income
|
1,170,233.97 | 1,075,137.36 | 953,907.07 | 686,943.31 | 535,338.57 |
|
Total Unusual Items
|
58,672 | 16,546 | 38,112 | -15,360 | -36,754 |
12/31/2022 - 6/15/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade